APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prostacyclin (PGI2) ELISA Kits

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Prostacyclin (PGI2) ELISA Kits Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025182 pages

Choose your research edition.

Industry ResearchProstacyclin (PGI2) ELISA Kits Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Prostacyclin (PGI2) ELISA Kits Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Prostacyclin (PGI2) ELISA Kits Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prostacyclin (PGI2) ELISA Kits Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Prostacyclin (PGI2) ELISA Kits Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Prostacyclin (PGI2) ELISA Kits market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Prostacyclin (PGI2) ELISA Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prostacyclin (PGI2) ELISA Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prostacyclin (PGI2) ELISA Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Prostacyclin (PGI2) ELISA Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Prostacyclin (PGI2) ELISA Kits include United States Biological, Fitzgerald Industries International, Enzo Life Sciences, Biomatik Corporation, Aspira Scientific, Abnova, Abcam and Abbexa Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Prostacyclin (PGI2) ELISA Kits market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prostacyclin (PGI2) ELISA Kits and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prostacyclin (PGI2) ELISA Kits sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prostacyclin (PGI2) ELISA Kits market size, projected growth trends, production technologies, key applications, and end-use industries.

Prostacyclin (PGI2) ELISA Kits Segment by Company

United States Biological

Fitzgerald Industries International

Enzo Life Sciences

Biomatik Corporation

Aspira Scientific

Abnova

Abcam

Abbexa Ltd

Prostacyclin (PGI2) ELISA Kits Segment by Type

Plasma

Serum

Other Biological Fluid

Prostacyclin (PGI2) ELISA Kits Segment by Application

Laboratories

Hospitals

Prostacyclin (PGI2) ELISA Kits Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostacyclin (PGI2) ELISA Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostacyclin (PGI2) ELISA Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostacyclin (PGI2) ELISA Kits.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Prostacyclin (PGI2) ELISA Kits market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prostacyclin (PGI2) ELISA Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Prostacyclin (PGI2) ELISA Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Prostacyclin (PGI2) ELISA Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Prostacyclin (PGI2) ELISA Kits Industry Trends Table 2. Prostacyclin (PGI2) ELISA Kits Industry Drivers Table 3. Prostacyclin (PGI2) ELISA Kits Industry Opportunities and Challenges Table 4. Prostacyclin (PGI2) ELISA Kits Industry Restraints Table 5. Global Prostacyclin (PGI2) ELISA Kits Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Prostacyclin (PGI2) ELISA Kits Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Prostacyclin (PGI2) ELISA Kits Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Prostacyclin (PGI2) ELISA Kits Sales Market Share by Manufacturers Table 9. Global Prostacyclin (PGI2) ELISA Kits Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Prostacyclin (PGI2) ELISA Kits Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Prostacyclin (PGI2) ELISA Kits Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Prostacyclin (PGI2) ELISA Kits Manufacturers, Product Type & Application Table 13. Global Prostacyclin (PGI2) ELISA Kits Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Prostacyclin (PGI2) ELISA Kits by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Plasma Table 17. Major Manufacturers of Serum Table 18. Major Manufacturers of Other Biological Fluid Table 19. Global Prostacyclin (PGI2) ELISA Kits Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Prostacyclin (PGI2) ELISA Kits Sales by Type (2021-2026) & (k units) Table 21. Global Prostacyclin (PGI2) ELISA Kits Sales by Type (2027-2032) & (k units) Table 22. Global Prostacyclin (PGI2) ELISA Kits Sales Market Share by Type (2021-2026) Table 23. Global Prostacyclin (PGI2) ELISA Kits Sales Market Share by Type (2027-2032) Table 24. Global Prostacyclin (PGI2) ELISA Kits Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Prostacyclin (PGI2) ELISA Kits Revenue by Type (2021-2026) & (k units) Table 26. Global Prostacyclin (PGI2) ELISA Kits Revenue by Type (2027-2032) & (k units) Table 27. Global Prostacyclin (PGI2) ELISA Kits Revenue Market Share by Type (2021-2026) Table 28. Global Prostacyclin (PGI2) ELISA Kits Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Laboratories Table 30. Major Manufacturers of Hospitals Table 31. Global Prostacyclin (PGI2) ELISA Kits Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Prostacyclin (PGI2) ELISA Kits Sales by Application (2021-2026) & (k units) Table 33. Global Prostacyclin (PGI2) ELISA Kits Sales by Application (2027-2032) & (k units) Table 34. Global Prostacyclin (PGI2) ELISA Kits Sales Market Share by Application (2021-2026) Table 35. Global Prostacyclin (PGI2) ELISA Kits Sales Market Share by Application (2027-2032) Table 36. Global Prostacyclin (PGI2) ELISA Kits Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Prostacyclin (PGI2) ELISA Kits Revenue by Application (2021-2026) & (k units) Table 38. Global Prostacyclin (PGI2) ELISA Kits Revenue by Application (2027-2032) & (k units) Table 39. Global Prostacyclin (PGI2) ELISA Kits Revenue Market Share by Application (2021-2026) Table 40. Global Prostacyclin (PGI2) ELISA Kits Revenue Market Share by Application (2027-2032) Table 41. Global Prostacyclin (PGI2) ELISA Kits Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Prostacyclin (PGI2) ELISA Kits Sales by Region (2021-2026) & (k units) Table 43. Global Prostacyclin (PGI2) ELISA Kits Sales Market Share by Region (2021-2026) Table 44. Global Prostacyclin (PGI2) ELISA Kits Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Prostacyclin (PGI2) ELISA Kits Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Prostacyclin (PGI2) ELISA Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Prostacyclin (PGI2) ELISA Kits Sales by Country (2021-2026) & (k units) Table 48. North America Prostacyclin (PGI2) ELISA Kits Sales by Country (2027-2032) & (k units) Table 49. Europe Prostacyclin (PGI2) ELISA Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Prostacyclin (PGI2) ELISA Kits Sales by Country (2021-2026) & (k units) Table 51. Europe Prostacyclin (PGI2) ELISA Kits Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Prostacyclin (PGI2) ELISA Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Prostacyclin (PGI2) ELISA Kits Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Prostacyclin (PGI2) ELISA Kits Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Prostacyclin (PGI2) ELISA Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Prostacyclin (PGI2) ELISA Kits Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Prostacyclin (PGI2) ELISA Kits Sales by Country (2027-2032) & (k units) Table 58. Global Prostacyclin (PGI2) ELISA Kits Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Prostacyclin (PGI2) ELISA Kits Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Prostacyclin (PGI2) ELISA Kits Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Prostacyclin (PGI2) ELISA Kits Revenue Market Share by Region (2021-2026) Table 62. Global Prostacyclin (PGI2) ELISA Kits Revenue Market Share by Region (2027-2032) Table 63. United States Biological Company Information Table 64. United States Biological Business Overview Table 65. United States Biological Prostacyclin (PGI2) ELISA Kits Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. United States Biological Prostacyclin (PGI2) ELISA Kits Product Portfolio Table 67. United States Biological Recent Development Table 68. Fitzgerald Industries International Company Information Table 69. Fitzgerald Industries International Business Overview Table 70. Fitzgerald Industries International Prostacyclin (PGI2) ELISA Kits Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Fitzgerald Industries International Prostacyclin (PGI2) ELISA Kits Product Portfolio Table 72. Fitzgerald Industries International Recent Development Table 73. Enzo Life Sciences Company Information Table 74. Enzo Life Sciences Business Overview Table 75. Enzo Life Sciences Prostacyclin (PGI2) ELISA Kits Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Enzo Life Sciences Prostacyclin (PGI2) ELISA Kits Product Portfolio Table 77. Enzo Life Sciences Recent Development Table 78. Biomatik Corporation Company Information Table 79. Biomatik Corporation Business Overview Table 80. Biomatik Corporation Prostacyclin (PGI2) ELISA Kits Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Biomatik Corporation Prostacyclin (PGI2) ELISA Kits Product Portfolio Table 82. Biomatik Corporation Recent Development Table 83. Aspira Scientific Company Information Table 84. Aspira Scientific Business Overview Table 85. Aspira Scientific Prostacyclin (PGI2) ELISA Kits Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Aspira Scientific Prostacyclin (PGI2) ELISA Kits Product Portfolio Table 87. Aspira Scientific Recent Development Table 88. Abnova Company Information Table 89. Abnova Business Overview Table 90. Abnova Prostacyclin (PGI2) ELISA Kits Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Abnova Prostacyclin (PGI2) ELISA Kits Product Portfolio Table 92. Abnova Recent Development Table 93. Abcam Company Information Table 94. Abcam Business Overview Table 95. Abcam Prostacyclin (PGI2) ELISA Kits Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Abcam Prostacyclin (PGI2) ELISA Kits Product Portfolio Table 97. Abcam Recent Development Table 98. Abbexa Ltd Company Information Table 99. Abbexa Ltd Business Overview Table 100. Abbexa Ltd Prostacyclin (PGI2) ELISA Kits Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Abbexa Ltd Prostacyclin (PGI2) ELISA Kits Product Portfolio Table 102. Abbexa Ltd Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. Prostacyclin (PGI2) ELISA Kits Distributors List Table 106. Prostacyclin (PGI2) ELISA Kits Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Prostacyclin (PGI2) ELISA Kits Product Image Figure 2. Global Prostacyclin (PGI2) ELISA Kits Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prostacyclin (PGI2) ELISA Kits Market Size (2021-2032) & (US$ Million) Figure 4. Global Prostacyclin (PGI2) ELISA Kits Sales (2021-2032) & (k units) Figure 5. Global Prostacyclin (PGI2) ELISA Kits Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Prostacyclin (PGI2) ELISA Kits Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Plasma Image Figure 9. Serum Image Figure 10. Other Biological Fluid Image Figure 11. Global Prostacyclin (PGI2) ELISA Kits Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Prostacyclin (PGI2) ELISA Kits Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Prostacyclin (PGI2) ELISA Kits Sales Market Share by Type (2021-2032) Figure 14. Global Prostacyclin (PGI2) ELISA Kits Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Prostacyclin (PGI2) ELISA Kits Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Prostacyclin (PGI2) ELISA Kits Revenue Market Share by Type (2021-2032) Figure 17. Laboratories Image Figure 18. Hospitals Image Figure 19. Global Prostacyclin (PGI2) ELISA Kits Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Prostacyclin (PGI2) ELISA Kits Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Prostacyclin (PGI2) ELISA Kits Sales Market Share by Application (2021-2032) Figure 22. Global Prostacyclin (PGI2) ELISA Kits Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Prostacyclin (PGI2) ELISA Kits Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Prostacyclin (PGI2) ELISA Kits Revenue Market Share by Application (2021-2032) Figure 25. North America Prostacyclin (PGI2) ELISA Kits Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Prostacyclin (PGI2) ELISA Kits Sales Market Share by Country (2021-2032) Figure 27. U.S. Prostacyclin (PGI2) ELISA Kits Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Prostacyclin (PGI2) ELISA Kits Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Prostacyclin (PGI2) ELISA Kits Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Prostacyclin (PGI2) ELISA Kits Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Prostacyclin (PGI2) ELISA Kits Sales Market Share by Country (2021-2032) Figure 32. Germany Prostacyclin (PGI2) ELISA Kits Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Prostacyclin (PGI2) ELISA Kits Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Prostacyclin (PGI2) ELISA Kits Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Prostacyclin (PGI2) ELISA Kits Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Prostacyclin (PGI2) ELISA Kits Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Prostacyclin (PGI2) ELISA Kits Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Prostacyclin (PGI2) ELISA Kits Sales Market Share by Country (2021-2032) Figure 39. China Prostacyclin (PGI2) ELISA Kits Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Prostacyclin (PGI2) ELISA Kits Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Prostacyclin (PGI2) ELISA Kits Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Prostacyclin (PGI2) ELISA Kits Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Prostacyclin (PGI2) ELISA Kits Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Prostacyclin (PGI2) ELISA Kits Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Prostacyclin (PGI2) ELISA Kits Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Prostacyclin (PGI2) ELISA Kits Sales Market Share by Country (2021-2032) Figure 47. Brazil Prostacyclin (PGI2) ELISA Kits Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Prostacyclin (PGI2) ELISA Kits Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Prostacyclin (PGI2) ELISA Kits Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Prostacyclin (PGI2) ELISA Kits Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Prostacyclin (PGI2) ELISA Kits Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Prostacyclin (PGI2) ELISA Kits Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Prostacyclin (PGI2) ELISA Kits Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Prostacyclin (PGI2) ELISA Kits Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Prostacyclin (PGI2) ELISA Kits Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Prostacyclin (PGI2) ELISA Kits Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Prostacyclin (PGI2) ELISA Kits Revenue (2021-2032) & (US$ Million) Figure 58. North America Prostacyclin (PGI2) ELISA Kits Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Prostacyclin (PGI2) ELISA Kits Revenue (2021-2032) & (US$ Million) Figure 60. Europe Prostacyclin (PGI2) ELISA Kits Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Prostacyclin (PGI2) ELISA Kits Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Prostacyclin (PGI2) ELISA Kits Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Prostacyclin (PGI2) ELISA Kits Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Prostacyclin (PGI2) ELISA Kits Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Prostacyclin (PGI2) ELISA Kits Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Prostacyclin (PGI2) ELISA Kits Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Plasma
  • Serum
  • Other Biological Fluid
Applications
  • Laboratories
  • Hospitals
Companies covered
  • United States Biological
  • Fitzgerald Industries International
  • Enzo Life Sciences
  • Biomatik Corporation
  • Aspira Scientific
  • Abnova
  • Abcam
  • Abbexa Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Prostacyclin (PGI2) ELISA Kits Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Prostacyclin (PGI2) ELISA Kits Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Prostacyclin (PGI2) ELISA Kits Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Prostacyclin (PGI2) ELISA Kits Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Prostacyclin (PGI2) ELISA Kits Market Dynamics
  1. 2.1 Prostacyclin (PGI2) ELISA Kits Industry Trends
  2. 2.2 Prostacyclin (PGI2) ELISA Kits Industry Drivers
  3. 2.3 Prostacyclin (PGI2) ELISA Kits Industry Opportunities and Challenges
  4. 2.4 Prostacyclin (PGI2) ELISA Kits Industry Restraints
3 Prostacyclin (PGI2) ELISA Kits Market by Manufacturers
  1. 3.1 Global Prostacyclin (PGI2) ELISA Kits Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Prostacyclin (PGI2) ELISA Kits Sales by Manufacturers (2021-2026)
  3. 3.3 Global Prostacyclin (PGI2) ELISA Kits Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Prostacyclin (PGI2) ELISA Kits Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Prostacyclin (PGI2) ELISA Kits Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Prostacyclin (PGI2) ELISA Kits Manufacturers, Product Type & Application
  7. 3.7 Global Prostacyclin (PGI2) ELISA Kits Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Prostacyclin (PGI2) ELISA Kits Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Prostacyclin (PGI2) ELISA Kits Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Prostacyclin (PGI2) ELISA Kits Tier 1, Tier 2, and Tier 3
4 Prostacyclin (PGI2) ELISA Kits Market by Type
  1. 4.1 Prostacyclin (PGI2) ELISA Kits Type Introduction
  2. 4.1.1 Plasma
  3. 4.1.2 Serum
  4. 4.1.3 Other Biological Fluid
  5. 4.2 Global Prostacyclin (PGI2) ELISA Kits Sales by Type
  6. 4.2.1 Global Prostacyclin (PGI2) ELISA Kits Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Prostacyclin (PGI2) ELISA Kits Sales by Type (2021-2032)
  8. 4.2.3 Global Prostacyclin (PGI2) ELISA Kits Sales Market Share by Type (2021-2032)
  9. 4.3 Global Prostacyclin (PGI2) ELISA Kits Revenue by Type
  10. 4.3.1 Global Prostacyclin (PGI2) ELISA Kits Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Prostacyclin (PGI2) ELISA Kits Revenue by Type (2021-2032)
  12. 4.3.3 Global Prostacyclin (PGI2) ELISA Kits Revenue Market Share by Type (2021-2032)
5 Prostacyclin (PGI2) ELISA Kits Market by Application
  1. 5.1 Prostacyclin (PGI2) ELISA Kits Application Introduction
  2. 5.1.1 Laboratories
  3. 5.1.2 Hospitals
  4. 5.2 Global Prostacyclin (PGI2) ELISA Kits Sales by Application
  5. 5.2.1 Global Prostacyclin (PGI2) ELISA Kits Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Prostacyclin (PGI2) ELISA Kits Sales by Application (2021-2032)
  7. 5.2.3 Global Prostacyclin (PGI2) ELISA Kits Sales Market Share by Application (2021-2032)
  8. 5.3 Global Prostacyclin (PGI2) ELISA Kits Revenue by Application
  9. 5.3.1 Global Prostacyclin (PGI2) ELISA Kits Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Prostacyclin (PGI2) ELISA Kits Revenue by Application (2021-2032)
  11. 5.3.3 Global Prostacyclin (PGI2) ELISA Kits Revenue Market Share by Application (2021-2032)
6 Global Prostacyclin (PGI2) ELISA Kits Sales by Region
  1. 6.1 Global Prostacyclin (PGI2) ELISA Kits Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prostacyclin (PGI2) ELISA Kits Sales by Region (2021-2032)
  3. 6.2.1 Global Prostacyclin (PGI2) ELISA Kits Sales by Region (2021-2026)
  4. 6.2.2 Global Prostacyclin (PGI2) ELISA Kits Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Prostacyclin (PGI2) ELISA Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Prostacyclin (PGI2) ELISA Kits Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Prostacyclin (PGI2) ELISA Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Prostacyclin (PGI2) ELISA Kits Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Prostacyclin (PGI2) ELISA Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Prostacyclin (PGI2) ELISA Kits Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Prostacyclin (PGI2) ELISA Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Prostacyclin (PGI2) ELISA Kits Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Prostacyclin (PGI2) ELISA Kits Revenue by Region
  1. 7.1 Global Prostacyclin (PGI2) ELISA Kits Revenue by Region
  2. 7.1.1 Global Prostacyclin (PGI2) ELISA Kits Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Prostacyclin (PGI2) ELISA Kits Revenue by Region (2021-2026)
  4. 7.1.3 Global Prostacyclin (PGI2) ELISA Kits Revenue by Region (2027-2032)
  5. 7.1.4 Global Prostacyclin (PGI2) ELISA Kits Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Prostacyclin (PGI2) ELISA Kits Revenue (2021-2032)
  8. 7.2.2 North America Prostacyclin (PGI2) ELISA Kits Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Prostacyclin (PGI2) ELISA Kits Revenue (2021-2032)
  11. 7.3.2 Europe Prostacyclin (PGI2) ELISA Kits Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Prostacyclin (PGI2) ELISA Kits Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Prostacyclin (PGI2) ELISA Kits Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Prostacyclin (PGI2) ELISA Kits Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Prostacyclin (PGI2) ELISA Kits Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 United States Biological
  2. 8.1.1 United States Biological Company Information
  3. 8.1.2 United States Biological Business Overview
  4. 8.1.3 United States Biological Prostacyclin (PGI2) ELISA Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 United States Biological Prostacyclin (PGI2) ELISA Kits Product Portfolio
  6. 8.1.5 United States Biological Recent Developments
  7. 8.2 Fitzgerald Industries International
  8. 8.2.1 Fitzgerald Industries International Company Information
  9. 8.2.2 Fitzgerald Industries International Business Overview
  10. 8.2.3 Fitzgerald Industries International Prostacyclin (PGI2) ELISA Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Fitzgerald Industries International Prostacyclin (PGI2) ELISA Kits Product Portfolio
  12. 8.2.5 Fitzgerald Industries International Recent Developments
  13. 8.3 Enzo Life Sciences
  14. 8.3.1 Enzo Life Sciences Company Information
  15. 8.3.2 Enzo Life Sciences Business Overview
  16. 8.3.3 Enzo Life Sciences Prostacyclin (PGI2) ELISA Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Enzo Life Sciences Prostacyclin (PGI2) ELISA Kits Product Portfolio
  18. 8.3.5 Enzo Life Sciences Recent Developments
  19. 8.4 Biomatik Corporation
  20. 8.4.1 Biomatik Corporation Company Information
  21. 8.4.2 Biomatik Corporation Business Overview
  22. 8.4.3 Biomatik Corporation Prostacyclin (PGI2) ELISA Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Biomatik Corporation Prostacyclin (PGI2) ELISA Kits Product Portfolio
  24. 8.4.5 Biomatik Corporation Recent Developments
  25. 8.5 Aspira Scientific
  26. 8.5.1 Aspira Scientific Company Information
  27. 8.5.2 Aspira Scientific Business Overview
  28. 8.5.3 Aspira Scientific Prostacyclin (PGI2) ELISA Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Aspira Scientific Prostacyclin (PGI2) ELISA Kits Product Portfolio
  30. 8.5.5 Aspira Scientific Recent Developments
  31. 8.6 Abnova
  32. 8.6.1 Abnova Company Information
  33. 8.6.2 Abnova Business Overview
  34. 8.6.3 Abnova Prostacyclin (PGI2) ELISA Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Abnova Prostacyclin (PGI2) ELISA Kits Product Portfolio
  36. 8.6.5 Abnova Recent Developments
  37. 8.7 Abcam
  38. 8.7.1 Abcam Company Information
  39. 8.7.2 Abcam Business Overview
  40. 8.7.3 Abcam Prostacyclin (PGI2) ELISA Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Abcam Prostacyclin (PGI2) ELISA Kits Product Portfolio
  42. 8.7.5 Abcam Recent Developments
  43. 8.8 Abbexa Ltd
  44. 8.8.1 Abbexa Ltd Company Information
  45. 8.8.2 Abbexa Ltd Business Overview
  46. 8.8.3 Abbexa Ltd Prostacyclin (PGI2) ELISA Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Abbexa Ltd Prostacyclin (PGI2) ELISA Kits Product Portfolio
  48. 8.8.5 Abbexa Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Prostacyclin (PGI2) ELISA Kits Value Chain Analysis
  2. 9.1.1 Prostacyclin (PGI2) ELISA Kits Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Prostacyclin (PGI2) ELISA Kits Production Mode & Process
  6. 9.2 Prostacyclin (PGI2) ELISA Kits Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Prostacyclin (PGI2) ELISA Kits Distributors
  9. 9.2.3 Prostacyclin (PGI2) ELISA Kits Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst